Stock comparison
BioAge Labs
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BIOA
BioAge Labs
Market cap
$625.36M
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BIOA | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 42D | 69B | MTD |
| Benjamin Graham | 42D | 65B | MTD |
| Philip Fisher | 65C | 63C | BIOA |
| Peter Lynch | 4F | 66B | MTD |
| Joel Greenblatt | 4F | 68B | MTD |
| Charlie Munger | 61D | 74B | MTD |
| Terry Smith | 64D | 70B | MTD |
Side-by-side metrics
| Metric | BIOA | MTD |
|---|---|---|
| Market cap | $625.36M | $22.29B |
| P/E (TTM) | - | 25.3x |
| EV/EBIT | - | 21.6x |
| ROIC (TTM) | -26.51% | 36.09% |
| Gross margin | 99.39% | 57.79% |
| Net margin | -8.72% | 21.4% |
| Revenue CAGR 5y | - | 2.01% |
| EPS CAGR 5y | - | 6.12% |
| Debt / Equity | 0.0x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BIOA leads on
- P/E (TTM)-vs 25.3x+131%
- EV/EBIT-vs 21.6x+119%
- Gross margin99.39%vs 57.79%+42%
MTD leads on
- ROIC (TTM)36.09%vs -26.51%+173%
- Net margin21.4%vs -8.72%+102%
- Debt / Equity-vs 0.0x+100%
- Market cap$22.29Bvs $625.36M+97%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.